Literature DB >> 12673205

Functional analysis of the N-terminal domain of the Myc oncoprotein.

Sara K Oster1, Daniel Y L Mao, James Kennedy, Linda Z Penn.   

Abstract

Myc is a multifunctional nuclear phosphoprotein that can drive cell cycle progression, apoptosis and cellular transformation. Myc orchestrates these activities at the molecular level by functioning as a regulator of gene transcription to activate or repress specific target genes. Previous studies have shown that both the Myc N-terminal domain (NTD) and the C-terminal domain (CTD) are essential for Myc functions. The role of the CTD is relatively well understood as it encodes a basic helix-loop-helix leucine zipper motif important for DNA binding and protein-protein interactions. By contrast, the role of the NTD and the specific domains responsible for different Myc activities are not as well defined. To investigate the regions of the NTD necessary for Myc function and to determine whether these activities are overlapping or independent of one another, we have conducted a detailed structure-function analysis of the Myc NTD. We assessed the ability of a number of deletion and point mutants within the highly conserved regions of the Myc NTD to induce cell cycle progression, apoptosis and transformation as well as repress and activate expression of endogenous target genes. Our analyses highlight the complexity of the Myc NTD and extend previous studies. For example, we show most Myc mutants that were compromised as repressors of gene transcription retained the ability to activate gene transcription, reinforcing the concept that these activities can be uncoupled. Repression of two different target genes could be distinguished by specific mutants, further supporting the notion of at least two different Myc repression mechanisms. Mutants disabled at both inducing and repressing gene transcription could not maximally drive the biological activities of Myc, indicating these functions are tightly linked. Indeed, a close association of Myc repression and apoptosis was also observed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12673205     DOI: 10.1038/sj.onc.1206228

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

1.  MYC-induced apoptosis in mammary epithelial cells is associated with repression of lineage-specific gene signatures.

Authors:  Heidi M Haikala; Juha Klefström; Martin Eilers; Katrin E Wiese
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

2.  New model systems provide insights into Myc-induced transformation.

Authors:  A R Wasylishen; A Stojanova; S Oliveri; A C Rust; A D Schimmer; L Z Penn
Journal:  Oncogene       Date:  2011-03-28       Impact factor: 9.867

Review 3.  MYC cofactors: molecular switches controlling diverse biological outcomes.

Authors:  Stephen R Hann
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-17       Impact factor: 6.915

4.  Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis.

Authors:  Kathryn A O'Donnell; Duonan Yu; Karen I Zeller; Jung-Whan Kim; Frederick Racke; Andrei Thomas-Tikhonenko; Chi V Dang
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

5.  Global MYCN transcription factor binding analysis in neuroblastoma reveals association with distinct E-box motifs and regions of DNA hypermethylation.

Authors:  Derek M Murphy; Patrick G Buckley; Kenneth Bryan; Sudipto Das; Leah Alcock; Niamh H Foley; Suzanne Prenter; Isabella Bray; Karen M Watters; Desmond Higgins; Raymond L Stallings
Journal:  PLoS One       Date:  2009-12-04       Impact factor: 3.240

6.  Point mutations in c-Myc uncouple neoplastic transformation from multiple other phenotypes in rat fibroblasts.

Authors:  J Anthony Graves; Kristi Rothermund; Tao Wang; Wei Qian; Bennett Van Houten; Edward V Prochownik
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

7.  Erroneous class switching and false VDJ recombination: molecular dissection of t(8;14)/MYC-IGH translocations in Burkitt-type lymphoblastic leukemia/B-cell lymphoma.

Authors:  Thomas Burmeister; Mara Molkentin; Stefan Schwartz; Nicola Gökbuget; Dieter Hoelzer; Eckhard Thiel; Richard Reinhardt
Journal:  Mol Oncol       Date:  2013-04-25       Impact factor: 6.603

Review 8.  SGF29 and Sry pathway in hepatocarcinogenesis.

Authors:  Nobuya Kurabe; Shigekazu Murakami; Fumio Tashiro
Journal:  World J Biol Chem       Date:  2015-08-26

Review 9.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Authors:  Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
Journal:  J Hematol Oncol       Date:  2021-08-09       Impact factor: 17.388

10.  Intrinsically disordered human C/EBP homologous protein regulates biological activity of colon cancer cells during calcium stress.

Authors:  Vinay K Singh; Ivan Pacheco; Vladimir N Uversky; Steven P Smith; R John MacLeod; Zongchao Jia
Journal:  J Mol Biol       Date:  2008-05-03       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.